Investors

2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014
DateTitle Download Print
03/22/17BrainStorm CEO to Present at the Sachs Associates 2nd Annual Neuroscience Biopartnering and Investment ForumDownload PDFPrinter Friendly Version
03/06/17BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical OfficerDownload PDFPrinter Friendly Version
03/01/17BrainStorm Announces MOU with Tel Aviv Sourasky Medical Center to Make NurOwn® Available to Patients as a Hospital Exemption ProductDownload PDFPrinter Friendly Version
02/27/17BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial SuccessDownload PDFPrinter Friendly Version
02/21/17BrainStorm Seeking Approval To Distribute NurOwn® in CanadaDownload PDFPrinter Friendly Version
02/16/17City of Hope to Manufacture NurOwn® for Brainstorm's Phase 3 ALS Clinical TrialDownload PDFPrinter Friendly Version
02/06/17BrainStorm CEO to Present at the BIO CEO & Investor ConferenceDownload PDFPrinter Friendly Version
01/30/17BrainStorm Announces Validation of NurOwn® Cryopreservation ProcessDownload PDFPrinter Friendly Version
01/17/17BrainStorm CEO to Present at the Phacilitate Cell & Gene Therapy World Conference 2017 in MiamiDownload PDFPrinter Friendly Version
01/05/17BrainStorm CEO to Present at the 9th Annual Biotech ShowcaseDownload PDFPrinter Friendly Version